Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2021/11/038257
CTRI/2021/11/038257
Recruiting
Phase 3

Study to evaluate safety and performance of Hydrophilic, Hydrophobic and PMMA intraocular lenses

Ophthalmic Marketing and Services Pvt Ltd0 sites0 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsHealth Condition 1: H590- Disorders of the eye following cataract surgery

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
Health Condition 1: H590- Disorders of the eye following cataract surgery
Sponsor
Ophthalmic Marketing and Services Pvt Ltd
Status
Recruiting
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
Ophthalmic Marketing and Services Pvt Ltd

Eligibility Criteria

Inclusion Criteria

  • •\-Subjects who have already undergone cataract surgery using IOL
  • •\-Calculated IOL power is within the range of the investigational IOL (\+ 6\.0 to 35\.0 Diopter)
  • •\-Subjects available after contact and willing to come for follow up during the clinical study.
  • •\-Subjects with signed informed consent
  • •Subject having clear intraocular media other than cataract

Exclusion Criteria

  • •\-Patients unwilling to participate in the study
  • •\-Subject with previous intraocular or corneal surgery
  • •\-Subject having traumatic cataract
  • •\-Pregnancy or lactation
  • •\-Concurrent participation in another drug or device investigation
  • •\-Instability of keratometry or biometry measurements
  • •\-Irregular astigmatism

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
A Pilot Study to Evaluate Safety and Efficacy of HLA-mismatched Granulocyte Transfusions in the Treatment of Patients with Solid Malignant Tumors Who Are Resistant to Standard Cancer Therapy or for Whom No Standard Cancer Therapy ExistsHealth Condition 1: null- CANCER
CTRI/2012/11/003116Munogenics Inc USA22
Recruiting
Phase 1
Thymol Dressing in Diabetic foot UlcerChronic neuropathic diabetic foot Ulcer.Type 2 diabetes mellitus with foot ulcerE11.621
IRCT20170612034485N3Iranian academic center for education culture and research20
Recruiting
Not Applicable
Effect of the herbal capsule containing aloe vera, flax leaves for curing constipation and comparing it with magnesium hydroxideComparison with Magnesium HydroxideConstipation.
IRCT20080901001165N38Bagheiat-allah University of Medical Sciences120
Completed
Phase 2
Haploidentical hematopoietic stem cell transplantation for the treatment of severe aplastic anemia patients.
IRCT20140818018842N29Tehran University of Medical Sciences10
Active, not recruiting
Not Applicable
Heat application to the eyelids to enhance ocular drug deliveryGlaucomaEye Diseases
ISRCTN22626706orth West Anglia NHS Foundation Trust24